Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 22 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 33 AND POTASSIUM CHLORIDE 0 22 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.33% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides calories and serves as a source of glucose, which is utilized for cellular energy metabolism. Sodium chloride provides sodium and chloride ions to maintain electrolyte balance and osmotic pressure. Potassium chloride provides potassium ions essential for cellular functions, including nerve conduction and muscle contraction, and helps correct or prevent hypokalemia.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion: 1000-2000 mL/day (25-50 mL/kg/day) titrated to fluid and electrolyte needs; maximum infusion rate 0.5 g/kg/hour dextrose.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Dextrose: not applicable as it is rapidly metabolized; glucose half-life is approximately 1.5-2 hours in normal individuals, prolonged in diabetes. Sodium and potassium: not defined as they are regulated by renal function.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Dextrose is metabolized to carbon dioxide and water; <1% excreted unchanged in urine. Sodium chloride and potassium chloride are excreted renally; >90% of filtered sodium and potassium is reabsorbed, with excretion balancing intake via renal regulation. Biliary/fecal excretion is negligible.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte